377 related articles for article (PubMed ID: 29908079)
1. Targeted brain proteomics uncover multiple pathways to Alzheimer's dementia.
Yu L; Petyuk VA; Gaiteri C; Mostafavi S; Young-Pearse T; Shah RC; Buchman AS; Schneider JA; Piehowski PD; Sontag RL; Fillmore TL; Shi T; Smith RD; De Jager PL; Bennett DA
Ann Neurol; 2018 Jul; 84(1):78-88. PubMed ID: 29908079
[TBL] [Abstract][Full Text] [Related]
2. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
[TBL] [Abstract][Full Text] [Related]
3. Cognition may link cortical IGFBP5 levels with motor function in older adults.
Buchman AS; Yu L; Petyuk VA; Gaiteri C; Tasaki S; Blizinsky KD; Schneider JA; De Jager PL; Bennett DA
PLoS One; 2019; 14(8):e0220968. PubMed ID: 31404102
[TBL] [Abstract][Full Text] [Related]
4. Microstructural changes in the brain mediate the association of AK4, IGFBP5, HSPB2, and ITPK1 with cognitive decline.
Kim N; Yu L; Dawe R; Petyuk VA; Gaiteri C; De Jager PL; Schneider JA; Arfanakis K; Bennett DA
Neurobiol Aging; 2019 Dec; 84():17-25. PubMed ID: 31479860
[TBL] [Abstract][Full Text] [Related]
5. Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons.
Capuano AW; Wilson RS; Honer WG; Petyuk VA; Leurgans SE; Yu L; Gatchel JR; Arnold S; Bennett DA; Arvanitakis Z
J Affect Disord; 2019 May; 250():313-318. PubMed ID: 30875674
[TBL] [Abstract][Full Text] [Related]
6. Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.
Zelaya MV; Pérez-Valderrama E; de Morentin XM; Tuñon T; Ferrer I; Luquin MR; Fernandez-Irigoyen J; Santamaría E
Oncotarget; 2015 Nov; 6(37):39437-56. PubMed ID: 26517091
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
8. To what degree is late life cognitive decline driven by age-related neuropathologies?
Boyle PA; Wang T; Yu L; Wilson RS; Dawe R; Arfanakis K; Schneider JA; Bennett DA
Brain; 2021 Aug; 144(7):2166-2175. PubMed ID: 33742668
[TBL] [Abstract][Full Text] [Related]
9. Relation of neuropathology to cognition in persons without cognitive impairment.
Bennett DA; Wilson RS; Boyle PA; Buchman AS; Schneider JA
Ann Neurol; 2012 Oct; 72(4):599-609. PubMed ID: 23109154
[TBL] [Abstract][Full Text] [Related]
10. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
[TBL] [Abstract][Full Text] [Related]
11. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
[TBL] [Abstract][Full Text] [Related]
12. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in Alzheimer's disease and common neuropathologies of aging.
Oveisgharan S; Arvanitakis Z; Yu L; Farfel J; Schneider JA; Bennett DA
Acta Neuropathol; 2018 Dec; 136(6):887-900. PubMed ID: 30334074
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease frequency peaks in the tenth decade and is lower afterwards.
Farfel JM; Yu L; Boyle PA; Leurgans S; Shah RC; Schneider JA; Bennett DA
Acta Neuropathol Commun; 2019 Jul; 7(1):104. PubMed ID: 31269985
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease.
Ramos-Miguel A; Sawada K; Jones AA; Thornton AE; Barr AM; Leurgans SE; Schneider JA; Bennett DA; Honer WG
Acta Neuropathol; 2017 Mar; 133(3):395-407. PubMed ID: 27866231
[TBL] [Abstract][Full Text] [Related]
16. Association of small vessel disease with tau pathology.
Kapasi A; Yu L; Petyuk V; Arfanakis K; Bennett DA; Schneider JA
Acta Neuropathol; 2022 Mar; 143(3):349-362. PubMed ID: 35044500
[TBL] [Abstract][Full Text] [Related]
17. Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies.
Boyle PA; Yu L; Leurgans SE; Wilson RS; Brookmeyer R; Schneider JA; Bennett DA
Ann Neurol; 2019 Jan; 85(1):114-124. PubMed ID: 30421454
[TBL] [Abstract][Full Text] [Related]
18. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
[TBL] [Abstract][Full Text] [Related]
19. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.
Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G
Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695
[TBL] [Abstract][Full Text] [Related]
20. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study.
Arvanitakis Z; Capuano AW; Leurgans SE; Bennett DA; Schneider JA
Lancet Neurol; 2016 Aug; 15(9):934-943. PubMed ID: 27312738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
